- Search for Research Summaries, Reviews, and Reports
- EPC Project
Related Products for this Topic
Published Journal Article
Research Review - Final – Aug. 14, 2012
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness
May be out of date: This report was assessed in December 2014 and some conclusions are possibly out of date.
Notice of Erratum: On August 20, 2012, Appendix O was updated to clarify that the route of administration for INVEGA SUSTENNA is IM injection (dosage 39 mg - 234 mg) and the route of administration for RISPERIDOL CONSTA is IM injection (dosage 25 mg).
People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us.